发明名称 ORAL FAST-MELT FORMULATION OF A CYCLOOXYGENASE-2 INHIBITOR
摘要 A process is provided for preparing an oral fast-melt composition of a selective cyclooxygenase-2 inhibitory drug, the process comprising (a) a step of wet granulating the drug together with a binding agent comprising a saccharide of high moldability, and (b) a step of blending with the drug a saccharide of low moldability, wherein the above steps (a) and (b) occur in any order or simulatenously to result in formation of granules. The process optionally incorporates means to inhibit agglomeration of the drug, for example addition of a wetting agent. Optionally the process further comprises (c) a step of blending the granules with at least one of a lubricant, a sweetening agent and a flavoring agent to form a tableting blend, and (d) a step of compressing the tableting blend to form oral fast-melt tablets. Also provided is a composition prepared by such a process.
申请公布号 WO0215885(A3) 申请公布日期 2003.08.28
申请号 WO2001US25803 申请日期 2001.08.17
申请人 PHARMACIA CORPORATION;YAMANOUCHI PHARMA TECHNOLOGIES, INC.;LE, TRANG, T.;KARARLI, TUGRUL, T.;KONTNY, MARK, J.;SASTRY, SRIKONDA, V.;NYSHADHAM, JANAKI, R.;PAGLIERO, ARTHUR, J., JR. 发明人 LE, TRANG, T.;KARARLI, TUGRUL, T.;KONTNY, MARK, J.;SASTRY, SRIKONDA, V.;NYSHADHAM, JANAKI, R.;PAGLIERO, ARTHUR, J., JR.
分类号 A61K9/20;A61K9/00;A61K9/16;A61K31/10;A61K31/122;A61K31/352;A61K31/353;A61K31/365;A61K31/415;A61K31/42;A61K31/444;A61K31/451;A61K31/485;A61K31/50;A61K31/635;A61K45/00;A61K47/02;A61K47/04;A61K47/10;A61K47/14;A61K47/18;A61K47/20;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61P1/04;A61P1/16;A61P5/24;A61P9/00;A61P11/00;A61P11/06;A61P15/00;A61P17/00;A61P19/02;A61P19/10;A61P25/00;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P29/02;A61P35/00;A61P43/00 主分类号 A61K9/20
代理机构 代理人
主权项
地址